🚚📦 Moving Your Business Forward with Reliable Logistics Solutions! Sampark India delivers safe, fast, and efficient logistics services across the country. 📞 24x7 Support: 91-9015150000 📧 info@silpl.com 🌐 silpl.rathigroup.info . . . #SamparkIndia #OneSolution #Logistics

A Warehouse Management System (WMS) improves inventory accuracy, reduces errors, and speeds up order fulfillment—helping businesses operate smarter and more efficiently. To know more, 🌐 silpl.rathigroup.info 📧 info@silpl.com 📞 24x7 91-9015150000 #SamparkIndia #OneSolution

Distance ho ya deadline, delivery chalti rahegi. With Sampark India Logistics, your cargo moves faster, safer, and on time every time. #SamparkIndia #OneSolution #Logistics #Shipping #Transport #AirCargo #Trucking #RailFreight #SafeShipping #FastTransport #LogisticsSolutions

One journey, too many disconnected steps but hashtag#ONESOLUTION to fix them all. Introducing hashtag#Kanak - Gold Lending, Simplified.

ONLY the balance of Madness have the chance to bring sanity in this country, everything else have proved to be less effective. #OneSolution #NoTo2030

They’re certainly “leading” the wrong way. If Californiawere an independent country, they would be a failed 3rd world country because federal funds are what’s keeping the whole state alive for years!! OneSolution: Nomorefederalfunds. Maybe Hilton will get elected. That would help!

Every step brings you closer — counting down from everything you’re dealing with… Then it lands in your hand. And just like that—things get smoother. Simpler. Easier. Meet the Redmi A7 Pro — built to simplify your everyday. #RedmiA7Pro #XiaomiGhana #OneSolution

One partner. Every solution. Premium. Reliable. Indian. ✨ Website: h-ssi.com #OneSolution #MadeInIndia #BusinessIndia

Een vriendin conductrice is dat overkomen .. nearly to death. En de overheid heeft het aan alle kanten laten af weten. Datzelfde gold voor een vriend die voor dood is achtergelaten .. gelukkig beide hersteld met een mega trauma .. deporteren met de hele familie ! #onesolution

Now there's only onesolution for men in this era, that is STOP MARRRYING cuz such thing can happen with any nice man who'll marry, u can be the next. I'm not discouraging men but talking logically. Hate me simps and feminist promiscuous di*ty evil females.

🚨🔥 FirePoint Energy Update: Merger Hype Builds! 10/16/2025 The ❌ confirms it: FirePoint Energy’s merger is still rolling, with CEO Mr. Smith eyeing a November finish. A new ticker’s coming, unlocking investment in their eco-friendly tech! Why It’s a Big Deal: XLPI’s low price is a golden opportunity, linked to Kim Clement’s prophecy of new energy rising from an eruption and quake. The #EnergyRevolution is near! Stay Plugged In: Follow for DAILY XLPI news, FINRA updates, and prophetic insights. Hit follow, enable notifications, and spread the word. Pray and let’s ride this! #firepointenergy #XLPI #ProphecyUnfolding #GreenEnergy #StayReady Disclaimer: Not financial advice—DYOR and consult pros before investing. Not affiliated with FINRA, FirePoint Energy, or XcelPlus International. Educational content only. Daily List: Symbol/Name Changes ❌ SINCD - Sincerity Applied Materials Holdings Corp. Common Stock CHANGED TO: ❌ SINC - Sincerity Applied Materials Holdings Corp. Common Stock ❌SNNF - Seneca Finl Corp Common Stock CHANGED TO: ❌SNNF - Seneca Bancorp, Inc. Common Stock ❌WRPT - WARPSPEED TAXI INC Common Stock CHANGED TO: ❌ULIX - Ulixe Corp. Common Stock ❌KRFGD - OneSolution Technology Inc. Common Stock CHANGED TO: ❌KRFG - OneSolution Technology Inc. Common Stock ❌DXTWF - DUXTON WTR LTD ORDINARY FULLY PAID (Australia) CHANGED TO: ❌DXTWF - RIVCO AUSTRALIA LTD Ordinary Shares

One unified system. Online to Offline. Simple, fast and secure. We just delivered the 3 pillars of our One-Single-Ecosystem vision for BOTH merchants and consumers and the response we got? Massive! Catch Ankit Gaur, Head of Online Merchants, PhonePe addressing our #Payments360 launch, featuring SmartPOD and Device Tokenisation solutions at GFF 2025. @Mastercard @ixigo #LaunchSuccess #ProductVision #UnifiedPayments #Payments #OneSolution #PhonePe #PaymentGateway #Secure #Simple #Speed

The majority of the Zimbabwean People are being deep-fried in poverty whilst a feel enjoy opulence which is financed through massive state looting. The time for Zimbabwe to offer each other solidarity through collective action and courage is now. #OneSolution #ArrestZvigananda

#OneSolution #RevolutionNow

Cysic Network offers an all-in-onesolution for zero-knowledge proof generation and verification. By leveraging both powerful and modest hardware, participants can contribute to the protocol and earn rewards from various ZK projects in return.

One subscription. Total clarity. With Occams Digital, SEO, ads, branding & more all connect seamlessly. Connect with us today: bit.ly/45nkQjH #DigitalClarity #OccamsDigital #SmartMarketing #BusinessGrowth #OneSolution

🏰 Why $AMGN Ohio and $MRK Winterfell Form the Dual Spine of the $NWBO #DCVax U.S. Immune Node Backbone 📜 Executive context and decision frame Northwest Biotherapeutics’ June 30, 2025 Form 10 Q confirmed that two finalist U.S. sites are under evaluation to assemble and dispatch patient specific DCVax immune regimens. Any chosen node must integrate Eden produced dendritic cell payloads, execute aseptic fill finish for Matrix class boosters such as viral mimics, cytokines, and recall vaccines, and support cryogenic staging with full chain of identity for autologous therapies. This briefing evaluates the two most credible pillars for that role. Merck’s WP50 at West Point Pennsylvania known as Winterfell which already operates like a cryo integrated immune operating system. And Amgen’s New Albany Ohio aseptic drug product facility which secured FDA operational approval in January 2024 and was designed for flexible biologics manufacturing using modern digital and simulation methods. 🏰 Merck WP50 Winterfell — integrated fortress model Foundational advantages • Site planning documents for Upper Gwynedd describe the West Point complex including the WP50 build which houses high grade sterile systems, plant utilities, and logistics infrastructure consistent with a vertically integrated fill finish hub that can co locate cold storage and materials movement. • Merck’s U.S. biologics infrastructure is complemented by modular drug substance capabilities that KeyPlants and others have documented, underscoring a corporate playbook for rapidly deployable suites that couple upstream and downstream with high containment and automation. Operational synthesis Winterfell is best understood as an on campus fortress. Cryogenic hold and staging can sit adjacent to controlled environments. DeltaV class automation orchestrates equipment and material flows. The practical result is a single site capable of pairing Eden payloads with multiple booster classes, including Merck owned recall vaccines such as Pneumovax twenty three, then releasing serialized kits with minimal handoffs. For a first wave of U.S. demand, this reduces failure points and speeds dispatch from one place. Regulatory posture A fortress model simplifies comparability and inspection because the complete system of manufacture, storage, and packaging resides under one established quality system with long standing FDA familiarity. This supports rapid adoption of bridging protocols that demonstrate product sameness when Eden is introduced as a process improvement after initial licensure. Strategic value Winterfell anchors the backbone. It offers maximal control of time, temperature, and traceability on a campus already aligned with oncology franchises. This adjacency matters if combination work, recall vaccine access, or rapid booster changes are required under post authorization variation frameworks. 🥇 Amgen New Albany Ohio — flexible industrial challenger What the facility is Amgen’s Ohio site was announced in 2021 and reached FDA operational approval for drug product manufacturing in January 2024, the most rapid site completion in Amgen’s history according to company materials. This was record speed for a sterile drug product facility, achieved in only three years during a period when most global pharma builds were delayed by pandemic supply chain disruption, regulatory backlogs, and shortages of cleanroom components. The fact that Amgen delivered on schedule during this environment underscores both the priority level given to the site and the effectiveness of its CRB-led ONEsolution design-build approach. Why the design matters for autologous workflows • CRB’s discrete event simulation methods model variable arrivals, small lot sizes, rapid changeovers, and resource contention, exactly the pain points of patient specific manufacturing. DES is used to right size cold storage, staffing, vial flows, and packaging cells before steel is set which lowers the risk of bottlenecks when real world demand is lumpy. • The facility is built as a high grade sterile drug product plant rather than a legacy bulk biologics workhorse, which means its suites and utilities are arranged for rapid line clearance, multiproduct segregation, and data rich batch records that regulators favor when approving comparability moves. How the cryogenic and logistics gap is solved without rebuilding the plant Amgen has used Cryoport for global temperature controlled logistics support. Cryoport’s filings describe agreements to support cryogenic shipments for Amgen which indicates compatibility with Amgen quality and IT systems for chain of identity and chain of custody. Cryoport has also expanded deeply in the United Kingdom advanced therapy ecosystem through a GMP logistics center at CGT Catapult’s Stevenage Manufacturing Innovation Centre, giving it established playbooks for serialized dry vapor shipper staging at approximately minus one hundred fifty degrees Celsius and for data integration through Cryoportal. This network can be mirrored to U.S. nodes that need immediate cryo staging without on site bay construction. Together, Amgen and Cryoport provide regulatory grade traceability that closes the gap with Winterfell’s on campus cryo. The difference is that Winterfell achieves integration through co location, while Amgen achieves the same outcome through partnership. What Amgen still needs and how it can be closed • Public documentation of multi component autologous kit co packaging is not yet available. The plant’s modular packaging areas combined with DSCSA compliant serialization can be configured for kit assembly if Amgen introduces dedicated cleanroom cells and quality controlled kitting procedures, which is an established pattern for modern sterile DP sites. • An Eden comparability protocol would be required. Amgen’s regulatory operations and quality systems are mature and well resourced which makes execution of a bridging package to show product sameness across manufacturing trains feasible within standard FDA and MHRA guidance. Financial and capacity signals Amgen continues to invest heavily in U.S. manufacturing capacity with recent announcements of large scale spend and job growth, reinforcing the corporate intent to operate flexible biologics plants at scale and to backfill capability gaps rapidly when commercial opportunities arise. Strategic synthesis The Ohio site is not a fortress by design. It is an industrial challenger that gains strength through digital design, rapid validation, and partnership based logistics. When paired with Cryoport’s cryogenic network and Amgen’s regulatory muscle, the site can meet the three demands for DCVax kit assembly which are Eden payload integration, sterile booster fill finish, and cryogenic staging with full serialization. 🧪 Scientific and CMC integration view Eden’s value proposition is a closed and automated dendritic cell workflow with standardized steps for monocyte isolation, maturation, and final formulation which reduces operator variability and supports reproducible release testing. A node that receives Eden grade payloads must demonstrate that downstream fill finish and kit assembly do not alter critical quality attributes such as identity, purity, potency, and viability. Winterfell satisfies this through on campus control. Amgen can satisfy this through tightly specified cleanroom operations, validated environmental controls, DES tuned scheduling to minimize time out of cryo, and a Cold Chain as a Service partner that provides continuous temperature and location telemetry for every patient lot. 🧰 Quality, release, and comparability Quality release for autologous kits requires rapid sterility and mycoplasma strategies, stability supported hold times, and data reconciliation across multiple systems. The easiest path is one QMS. Winterfell provides that in house. Amgen can achieve the same outcome by integrating digital batch records with Cryoport’s chain of condition data and by adopting a master comparability protocol that defines analytical sameness when Eden parameters or booster suppliers change. Cross site governance with clear assay ownership and reference standard management will keep lot release within a one to three day window which is the practical bar for patient specific oncology products. 🧭 Regulatory positioning and risk • Both nodes will require agency accepted comparability plans when Eden is introduced as a post authorization process improvement. Winterfell’s single site control reduces the number of variables. Amgen’s process simulation and validation toolset allows pre specification of ranges that simplify review. • U.S. and UK regulators look for redundancy and business continuity in autologous supply chains. A fortress and an industrial challenger together provide orthogonal risk reduction which is persuasive during late stage reviews and inspection planning. • Public communications must remain careful. Nothing in this briefing asserts approval or label scope. It frames operational fitness for a potential role after appropriate regulatory clearances. 🧩 Strategic narrative and leadership lens Linda Powers has consistently pursued a multi node strategy to avoid single point failure, to keep negotiating leverage, and to build a platform that can take on new boosters and indications without pausing supply. The best configuration is a dual spine. Winterfell as the integrated fortress that can run early volumes with minimal external dependencies. Amgen Ohio as the flexible challenger that scales and regionalizes supply using digital design and a proven cryogenic logistics partner. There is an echo of Amgen’s own origin story here. Amgen began life as a single asset bet and then compounded into a platform company by mastering biologics manufacturing and the regulatory craft that sits behind it. New Albany is the physical manifestation of that institutional memory. The plant exists to turn scientific bets into repeatable and inspectable product at speed. That is the same transformation $NWBO seeks as Eden moves from validation to scaled deployment. ✅ Decision oriented verdict • If the objective is maximal near term certainty with the fewest moving parts, prioritize Winterfell as the first U.S. node. It already functions like a closed immune system factory inside a single campus QMS, with proximity to recall vaccine supply and oncology combinations. • If the objective is to add a second U.S. node that can scale, mirror, and regionalize at pace, elevate Amgen Ohio. FDA operational approval is already in place, the facility was designed for variable small lot workflows, and the cryogenic and kitting gaps can be closed with Cryoport and targeted cleanroom configuration. This fortress plus challenger spine provides operational resilience, regulatory credibility, and financial flexibility for a staged U.S. rollout while Eden drives labor reduction and consistency. 📚 Sources NWBO Form 10 Q for the period ended June 30, 2025. Upper Gwynedd Township planning packet that includes Merck West Point WP50 information. Merck biologics drug substance facility modular capability overview by KeyPlants. Amgen Goes OH IO with Opening of Newest Manufacturing Facility which notes January 2024 FDA approval for operation. CRB Group Aseptic and Sterile Drug Product Facility ONEsolution reference. CRB white paper on discrete event simulation for autologous cell therapy manufacturing. Amgen manufacturing expansion and job creation materials. Cryoport financial documents noting support for Amgen cryogenic shipments. Cryoport announcement of GMP logistics center with CGT Catapult in Stevenage for UK advanced therapies. 📝 Disclosure This analysis synthesizes public documents and standard regulatory practice. It is not investment advice. Clinical, regulatory, and commercial outcomes remain uncertain. No confidential information is used. Investors should conduct independent due diligence and monitor official regulatory sources for definitive updates.

Tagwirei is mobilizing a popular revolution for the masses to take over the means of production. He is right, land and minerals are in the hands of a few. The masses should stop looking for jobs and take over the means of production. #OneSolution #Revolution

Rounding out July we have Coach’s Neighborhood Grill in Reidsville, NC! The largest of all the Coach’s, the staff here were beyond excited to move to @SkyTabPOS Powered by @Shift4 and away from their previous oneSolution.

We must never forget that on this day exactly 7 years ago, the dictatorship in Harare fired live ammunition on unarmed civilians who were exercising their constitutional rights, resulting in the deaths of at least 6 people! We didn't forget! #ZanuPfMustGo #OneSolution #Revolution